| Price | 952.00p on 07-04-2026 at 10:05:14 |
|---|---|
| Change | 18.00p 1.93% |
| Buy | 958.00p |
| Sell | 946.00p |
| Last Trade: | Unknown 145.00 at 949.00p |
| Day's Volume: | 93,243 |
| Last Close: | 934.00p |
| Open: | 940.00p |
| ISIN: | GB0004559349 |
| Day's Range | 938.00p - 960.00p |
| 52wk Range: | 480.00p - 1,000.00p |
| Market Capitalisation: | £303.71m |
| VWAP: | 942.74187p |
| Shares in Issue: | 31.90m |
Sector: Closed End Investments
Listed In: FTSE All-Share, FTSE Small Cap
Int.biotech. (IBT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 145 | 949.00p | OTC Trade |
10:46:16 - 07-Apr-26 |
| Sell* | 145 | 949.00p | SI Trade |
10:46:16 - 07-Apr-26 |
| Buy* | 317 | 952.00p | Automatic Execution |
10:46:16 - 07-Apr-26 |
| Buy* | 100 | 952.00p | Automatic Execution |
10:46:16 - 07-Apr-26 |
| Sell* | 750 | 944.00p | Automatic Execution |
10:46:16 - 07-Apr-26 |
| Sell* | 627 | 946.00p | Automatic Execution |
10:46:16 - 07-Apr-26 |
| Sell* | 750 | 946.00p | Automatic Execution |
10:46:16 - 07-Apr-26 |
| Buy* | 1,508 | 952.00p | Automatic Execution |
10:46:09 - 07-Apr-26 |
| Sell* | 553 | 952.00p | Automatic Execution |
10:46:09 - 07-Apr-26 |
| Sell* | 1,503 | 954.00p | Automatic Execution |
10:46:09 - 07-Apr-26 |
Int.biotech. (IBT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st Apr 2026 5:24 pm | RNS | Transaction in Own Shares |
| 1st Apr 2026 12:02 pm | RNS | Net Asset Value(s) |
| 31st Mar 2026 2:55 pm | RNS-R | IBT portfolio company Apellis acquired by Biogen |
| 31st Mar 2026 12:00 pm | RNS | Net Asset Value(s) |
| 30th Mar 2026 11:46 am | RNS | Net Asset Value(s) |
| 27th Mar 2026 11:51 am | RNS | Net Asset Value(s) |
| 26th Mar 2026 11:56 am | RNS | Net Asset Value(s) |
| 25th Mar 2026 2:43 pm | RNS-R | IBT portfolio company Terns acquired by Merck |
| 25th Mar 2026 12:01 pm | RNS | Net Asset Value(s) |
| 24th Mar 2026 11:54 am | RNS | Net Asset Value(s) |
